IEZZI, ANNALISA
 Distribuzione geografica
Continente #
NA - Nord America 433
EU - Europa 364
AS - Asia 175
Totale 972
Nazione #
US - Stati Uniti d'America 433
UA - Ucraina 67
CN - Cina 66
SE - Svezia 53
IE - Irlanda 52
FR - Francia 50
IT - Italia 46
TR - Turchia 44
GB - Regno Unito 43
SG - Singapore 40
IN - India 24
DE - Germania 19
FI - Finlandia 13
RU - Federazione Russa 10
BE - Belgio 7
CZ - Repubblica Ceca 3
IL - Israele 1
NO - Norvegia 1
Totale 972
Città #
Chandler 91
Jacksonville 66
Dublin 52
Ann Arbor 44
Singapore 33
Ashburn 26
New York 26
Southend 26
Princeton 22
Izmir 20
Chieti 18
Beijing 13
Nanjing 12
Wilmington 12
Cambridge 11
Woodbridge 11
Altamura 10
Nanchang 10
Dearborn 9
Washington 9
Brussels 7
Boardman 6
Kunming 6
Los Angeles 6
Santa Clara 5
Tianjin 5
Grevenbroich 4
Hefei 4
Foggia 3
Hangzhou 3
Hebei 3
Moscow 3
Pescara 3
San Mateo 3
Auburn Hills 2
Brno 2
Guangzhou 2
Hanover 2
Helsinki 2
Lanzhou 2
Rome 2
San Salvo 2
Seattle 2
Tortoreto 2
Jiaxing 1
Jinan 1
Leawood 1
Milan 1
Mumbai 1
Norwalk 1
Orange 1
Paris 1
Penne 1
Prague 1
Shenyang 1
Taizhou 1
Zhengzhou 1
Totale 615
Nome #
Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes. 115
Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. 113
Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. 101
Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteases activity 97
Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human. 95
Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. 91
A Polymorphism in the Cyclooxygenase 2 Gene as an Inherited Protective Factor Against Myocardial Infarction and Stroke 83
Association between 5-lipoxygenase expression and plaque instability in humans. 81
Relationship between reduced BCL-2 expression in circulating mononuclear cells and early nephropathy in type 1 diabetes. 79
Enhanced soluble CD40 Ligand is responsible for endothelial dysfunction and monocyte activation in patients with diabetes mellitus. Effect of improved metabolic control. 69
COX-2: friend or foe? 67
Totale 991
Categoria #
all - tutte 3.585
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.585


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020108 0 0 3 9 3 9 20 19 8 17 16 4
2020/202192 12 0 14 1 8 20 2 0 13 13 1 8
2021/202268 3 1 2 12 6 2 4 1 6 8 8 15
2022/2023220 15 34 12 33 25 41 8 8 34 2 5 3
2023/2024124 5 3 13 1 9 57 20 3 3 3 0 7
2024/202565 14 34 17 0 0 0 0 0 0 0 0 0
Totale 991